Saol Therapeutics
PrivateLast Round
Growth Equity
Feb 1, 2017
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Saol Therapeutics operates in Healthcare & Life Sciences and is based in Roswell, Georgia. Its latest recorded funding round was a Growth Equity round in February 2017.
Saol Therapeutics is a biopharmaceutical company focused on the clinical development of therapies for central nervous system disorders and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saol Therapeutics Comparables
Compare Saol Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Khondrion | 76% | |
| Minoryx Therapeutics | 76% | |
| PTC Therapeutics Inc | 73% |
For institutional investors. Book with your work email.
Saol Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Saol Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avego Management | Growth Equity |
| DFW Capital Partners | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 65% MoM.
- Jul 24, 2026
Monthly visitors increased 64% MoM.
For institutional investors. Book with your work email.
Saol Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Saol Therapeutics's valuation, stock price, and market status.
Is Saol Therapeutics a public or private company?
Saol Therapeutics is a private company.
What is the current stock price of Saol Therapeutics?
Saol Therapeutics is a private company, so its shares have no public market price. Caplight tracks Saol Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Saol Therapeutics worth (valuation)?
Valuation information for Saol Therapeutics is not publicly available.
Can I buy Saol Therapeutics stock?
Saol Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Saol Therapeutics's last funding round?
Saol Therapeutics's most recent funding round was Growth Equity on February 1, 2017.
Who are the main investors in Saol Therapeutics?
Key investors in Saol Therapeutics include Avego Management, DFW Capital Partners.
Will Saol Therapeutics IPO soon?
No public IPO plans have been announced for Saol Therapeutics.
How can I track Saol Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Saol Therapeutics's shares on secondary markets.